Phase II study of dynamic tumor tracking intensity-modulated radiotherapy in patients with locally advanced pancreatic cancer
Phase 2
- Conditions
- Pancreatic cancer
- Registration Number
- JPRN-UMIN000017521
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1) Intersitial pneumonia or pulmonary fibrosis 2) previous irradiation to upper abdomen 3) Severe comorbidity 4) Pleural effusion or Ascites 5) Tumor invasion to stomach, duodenum or intestine 6) Patients with double cancer (double cancer or treated cancer with no more than 3-year disease-free period). However, carcinoma in situ or intra-mucosal cancer-equivalent lesion are not to be included in double cancer 7) Severe allergy history to gold 8) Unstable and Uncontrollable diabetic mellitus, or severe collagen disease 9) Woman during pregnancy or breast-feeding, patient who wish pregnancy 10) Psychiatric disease 11) Inappropriate patients for this study judged by physicians
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1-year freedom from loco-regional progression
- Secondary Outcome Measures
Name Time Method oco-regional progression-free survival, overall survival, progression-free survival, the incidence of acute adverse events, the incidence of late adverse events, treatment-related morbidity/early mortality , the accuracy in dynamic tumor tracking technique